Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 8 | 2009 | 91 | 0.880 |
Why?
|
| Diterpenes | 6 | 2009 | 83 | 0.540 |
Why?
|
| Conotoxins | 3 | 2004 | 18 | 0.530 |
Why?
|
| Torpedo | 12 | 2004 | 41 | 0.440 |
Why?
|
| Electric Organ | 7 | 1998 | 18 | 0.410 |
Why?
|
| Receptors, Cholinergic | 6 | 2001 | 28 | 0.330 |
Why?
|
| Peptides, Cyclic | 2 | 1997 | 30 | 0.280 |
Why?
|
| Nicotinic Antagonists | 3 | 2001 | 28 | 0.260 |
Why?
|
| Tyrosine | 1 | 2004 | 109 | 0.250 |
Why?
|
| Protein Subunits | 1 | 2004 | 85 | 0.250 |
Why?
|
| Binding, Competitive | 7 | 2004 | 103 | 0.220 |
Why?
|
| Fatty Alcohols | 1 | 2001 | 7 | 0.210 |
Why?
|
| Anesthetics | 1 | 2001 | 10 | 0.210 |
Why?
|
| Mollusk Venoms | 2 | 1997 | 21 | 0.180 |
Why?
|
| Binding Sites | 6 | 2001 | 597 | 0.180 |
Why?
|
| Bungarotoxins | 5 | 2004 | 21 | 0.160 |
Why?
|
| Arginine | 1 | 1997 | 62 | 0.150 |
Why?
|
| Gangliosides | 1 | 1996 | 7 | 0.150 |
Why?
|
| Cholinergic Antagonists | 1 | 1995 | 8 | 0.140 |
Why?
|
| Ion Channels | 1 | 1995 | 69 | 0.130 |
Why?
|
| Phencyclidine | 5 | 2001 | 17 | 0.120 |
Why?
|
| Animals | 15 | 2009 | 14307 | 0.120 |
Why?
|
| Molecular Sequence Data | 5 | 1998 | 1490 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 1997 | 1124 | 0.090 |
Why?
|
| Anthozoa | 1 | 2009 | 24 | 0.090 |
Why?
|
| Ion Channel Gating | 3 | 1997 | 81 | 0.080 |
Why?
|
| Radioligand Assay | 2 | 2004 | 61 | 0.070 |
Why?
|
| Xenopus laevis | 4 | 1998 | 73 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 168 | 0.060 |
Why?
|
| Cell Line | 3 | 2004 | 1289 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2004 | 207 | 0.060 |
Why?
|
| Transfection | 1 | 2004 | 496 | 0.060 |
Why?
|
| Protein Binding | 2 | 2004 | 913 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 1993 | 48 | 0.060 |
Why?
|
| Hexanols | 1 | 2001 | 2 | 0.050 |
Why?
|
| Procaine | 1 | 2001 | 2 | 0.050 |
Why?
|
| Octanols | 1 | 2001 | 7 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2001 | 22 | 0.050 |
Why?
|
| Plants, Toxic | 1 | 2001 | 7 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 1993 | 338 | 0.050 |
Why?
|
| Acetylcholine | 2 | 1998 | 68 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2001 | 210 | 0.050 |
Why?
|
| Cell Membrane | 3 | 1998 | 360 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1998 | 52 | 0.040 |
Why?
|
| Nicotine | 1 | 2001 | 238 | 0.040 |
Why?
|
| Mice | 4 | 2004 | 5668 | 0.040 |
Why?
|
| Motor Activity | 1 | 2001 | 393 | 0.040 |
Why?
|
| Batrachotoxins | 1 | 1997 | 1 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 1997 | 7 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1997 | 16 | 0.040 |
Why?
|
| RNA | 1 | 1998 | 234 | 0.040 |
Why?
|
| G(M2) Ganglioside | 1 | 1996 | 3 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 7 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 1996 | 37 | 0.040 |
Why?
|
| Cocaine | 1 | 1998 | 219 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 137 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 44 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1995 | 52 | 0.030 |
Why?
|
| Fatty Acids | 1 | 1996 | 118 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1995 | 350 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 1994 | 68 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 376 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1995 | 201 | 0.030 |
Why?
|
| Neurons | 1 | 2001 | 1130 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1993 | 6 | 0.030 |
Why?
|
| Cnidaria | 1 | 1993 | 8 | 0.030 |
Why?
|
| Terpenes | 1 | 1993 | 28 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1993 | 63 | 0.030 |
Why?
|
| Polyamines | 1 | 1992 | 28 | 0.030 |
Why?
|
| Spermine | 1 | 1992 | 64 | 0.030 |
Why?
|
| Oocytes | 3 | 1997 | 143 | 0.020 |
Why?
|
| Tromethamine | 1 | 1989 | 5 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1989 | 63 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 231 | 0.020 |
Why?
|
| Female | 3 | 2001 | 19873 | 0.020 |
Why?
|
| Ligands | 2 | 1998 | 317 | 0.020 |
Why?
|
| Organ Specificity | 2 | 1993 | 123 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 756 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1317 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 485 | 0.010 |
Why?
|
| Humans | 1 | 2004 | 34853 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2001 | 141 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 24 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 257 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1998 | 142 | 0.010 |
Why?
|
| Tritium | 1 | 1997 | 48 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 33 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1997 | 39 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 546 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 92 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 650 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1442 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 214 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 932 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1534 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 3261 | 0.010 |
Why?
|
| Tetracaine | 1 | 1993 | 4 | 0.010 |
Why?
|
| Cnidarian Venoms | 1 | 1993 | 23 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 249 | 0.010 |
Why?
|
| Magnesium | 1 | 1993 | 95 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1993 | 213 | 0.010 |
Why?
|
| Rubidium | 1 | 1992 | 6 | 0.010 |
Why?
|
| Carbachol | 1 | 1992 | 18 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1993 | 467 | 0.010 |
Why?
|
| Chemistry | 1 | 1989 | 17 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1989 | 53 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1989 | 58 | 0.010 |
Why?
|
| Action Potentials | 1 | 1989 | 219 | 0.000 |
Why?
|